SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

Share Price is delayed by 15 minutes
Get Live Data
3.75    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.50 (14.286%)
Market Cap: £1.19m
SNT Live PriceLast checked at - London Stock Exchange

Intraday Sabien Tech. Share Chart

Trading Statement

29 May 2014 07:00

RNS Number : 2865I
Sabien Technology Group PLC
29 May 2014
 



Sabien Technology Group plc

("Sabien" or "the Company")

Trading Update

The Board of Sabien Technology Group plc (AIM: SNT), the manufacturer and supplier of M2G, an energy efficiency technology, announces that, in light of recently delayed orders, the Company now expects to report a loss of up to c.£0.3m in the financial year to June 30 2014.

The shortfall in revenue relative to management expectations is due to a delay in the receipt of some substantial customer orders that were expected to be received in the second half of the financial year but which now are expected in the first half of the next financial year.

In line with management expectations administrative expenses for the current financial year are c.£0.5m higher than last year due primarily to the increase in Business Development Manager headcount but also the investment in the indirect channel for overseas development, the move to larger offices and the expenditure on new product development.

The investment made in new Business Development Managers in the first half of this financial year is beginning to produce returns as a number of sales pipeline opportunities are now maturing into orders. The Company is also continuing to expand its overseas distribution network and since February 2014 has added M2G distributors in China, Greece, Pakistan, Iran, UAE, Spain, Israel, Australasia and South Africa. To date we have received initial small orders from these distributors and we expect further growth in both the size of future orders and the number of distributors in the next year. The sales pipeline currently stands at £5.8m which compares with £6.6m at the time of the February trading update and £4.6m as at 30 June 2013.

During the current financial year, the Company has developed a new product for use on hot water calorifiers (small water heaters) which have been previously too small to install an M2G. Based on the analysis of previous roll-outs of M2G, the Company estimates that these calorifiers could represent up to 20% of all the boilers on a typical estate. Results of 'infield' client trials have proven that considerable savings can be made and, as a consequence, we will be launching this new product later in the calendar year.

Despite the delays in orders received, the Company expects to start the new financial year on 1 July 2014 with an order book of at least £0.5m and this, alongside the potential for new revenue sources from the new product and from our overseas distribution network as well as the growth in the existing sales pipeline, gives the Board confidence in the Company's growth prospects.

The Company's net cash position remains strong and, despite the loss forecast for the year, is expected to be at least at the same level at 30 June 2014 as it was at 30 June 2013 (£1.36m). The reason is due to the reduction in working capital over the period.

The Board believes that Sabien has sufficient capital to execute its business plan and deliver the anticipated growth in the years ahead. As a result of the strong cash position and the expectation that work on the delayed orders will commence in the second half of the calendar year, the Board expects to be in a position to continue with its progressive dividend policy following the maiden dividend announced in 2013.

A further trading update will be provided to the market after the end of the current financial year.

Commenting on trading, Alan O'Brien, Chief Executive of Sabien said:

"Although the reduction in revenue this year has been a source of frustration for the management team and me, there have not been any contract cancellations, only delays in the placing of orders.

This year has seen material progress in a number of areas. We have broadened our business development capabilities, signed commercial M2G distribution agreements in Europe, Middle East, Asia and Australasia, and developed and piloted a new product for hot water calorifiers which we intend to launch later in 2014. This is expected to lead to a wider application of our products in our target markets.

I am confident that Sabien's prospects for the medium and long-term remain positive and there is still a substantial market opportunity to create a profitable and valuable business moving forward."

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFSRELITFIS
Date   Source Headline
10th Mar 20217:00 amRNSCorporate Update - US Subsidiary Established
8th Mar 202110:59 amRNSCorporate Update - Contract win
5th Mar 202112:32 pmRNSNotice of Annual General Meeting
5th Mar 20217:00 amRNSAppointment of Chief Financial Officer
3rd Mar 20214:33 pmRNSHolding(s) in Company
3rd Mar 202110:00 amRNSHolding(s) in Company
1st Mar 20215:06 pmRNSHolding(s) in Company
1st Mar 20217:00 amRNSHolding(s) in Company
26th Feb 20215:00 pmRNSTotal Voting Rights
26th Feb 202110:47 amRNSSignificant investment in emerging technology
24th Feb 20212:10 pmRNSHolding(s) in Company
24th Feb 202112:16 pmRNSHolding(s) in Company
23rd Feb 20213:45 pmRNSChange of Registered Office
22nd Feb 202110:35 amRNSResult of General Meeting and Total Voting Rights
12th Feb 20217:00 amRNSHolding(s) in Company
11th Feb 202111:03 amRNSHolding(s) in Company
10th Feb 202111:38 amRNSHolding(s) in Company
3rd Feb 20214:11 pmRNSPlacing and Notice of General Meeting
1st Feb 20217:00 amRNSAppointment of Non-Executive Director
28th Jan 20214:32 pmRNSHolding(s) in Company
28th Jan 20218:14 amRNSHolding(s) in Company
27th Jan 20211:28 pmRNSChange of Substantial Shareholding
27th Jan 20211:26 pmRNSHolding(s) in Company
25th Jan 20217:00 amRNSBoard Changes
20th Jan 20217:30 amRNSRestoration - Sabien Technology Group PLC
20th Jan 20217:00 amRNSWithdrawal from acquisition and other matters
12th Jan 20215:38 pmRNSFrequently asked questions regarding the GM
5th Jan 20217:00 amRNSPosting of Circular and Notice of General Meeting
21st Dec 20205:23 pmRNSHolding(s) in Company
21st Dec 20205:20 pmRNSHolding(s) in Company
2nd Dec 20205:14 pmRNSPosting of Annual Report and Accounts
19th Nov 20207:00 amRNSFinal Results & Update on Proposed Acquisition
5th Nov 20207:00 amRNSChange of Registered Office
2nd Nov 20207:00 amRNSUpdate on Acquisition
14th Sep 20203:30 pmRNSCorporate Update - Contract win
27th Jul 20207:00 amRNSChange of Adviser
27th Jul 20207:00 amRNSUpdate re. Suspension
6th Jul 20207:00 amRNSTrading Update
29th May 202011:15 amRNSManagement Change, Furlough Update
31st Mar 20207:00 amRNSSabien furloughs staff in response to C19 lockdown
20th Mar 20207:00 amRNSHalf-year Report
18th Mar 20207:00 amRNSChange of Adviser
20th Jan 20207:30 amRNSSuspension - Sabien Technology Group plc
20th Jan 20207:30 amRNSStatement re Press Comment
10th Jan 20202:00 pmRNSPrice Monitoring Extension
10th Jan 20201:30 pmRNSIssue of Equity
10th Jan 202010:15 amRNSHolding(s) in Company
8th Jan 20201:15 pmRNSResult of Meeting
19th Dec 201912:30 pmRNSApplication for admission
17th Dec 20194:35 pmRNSNotice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.